Skip to main content
CCLD
NASDAQ Technology

CareCloud Achieves First Full-Year Positive EPS Since IPO, Exceeds Revenue Guidance, and Issues Strong 2026 Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.81
Mkt Cap
$112.776M
52W Low
$1.142
52W High
$4.01
52W Position info
146% above low
Off High info
30% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CCLD has more than doubled off its 52-week low of $1.142.

Summary

CareCloud, Inc. announced its first full-year positive GAAP EPS since its IPO, exceeded revenue guidance, and provided strong 2026 financial projections, alongside strategic progress in AI and acquisitions.


Key Events · Earnings and Guidance · CCLD

  • First Full-Year Positive EPS Since IPO

    CareCloud reported GAAP EPS of $0.10 for the full year 2025, marking its first positive full-year EPS since its 2014 IPO, a significant improvement from ($0.28) in 2024.

  • Exceeded Full-Year Revenue Guidance

    The company achieved full-year 2025 revenue of $120.5 million, an 8.7% increase over 2024, surpassing its previously increased guidance.

  • Strong 2026 Financial Outlook

    CareCloud issued 2026 guidance projecting GAAP EPS of $0.20-$0.23 (100-130% increase) and revenue of $128-$132 million, indicating continued growth and profitability.

  • Strategic AI & Acquisition Progress

    Key accomplishments include entry into the inpatient software market via strategic acquisitions and the launch of new AI products like stratusAI Desk Agent and stratusAI Voice Audit.


Analysis · CCLD · Technology

CareCloud, Inc. reported a significant financial turnaround, achieving its first full-year positive GAAP EPS of $0.10 since its 2014 IPO, a substantial improvement from ($0.28) in the prior year. The company also exceeded its full-year revenue guidance, reaching $120.5 million, an 8.7% increase year-over-year. Looking ahead, CareCloud provided robust 2026 guidance, projecting GAAP EPS of $0.20-$0.23, representing a 100-130% increase, and revenue between $128 million and $132 million. These positive financial results are further supported by strategic advancements, including entry into the inpatient software market through acquisitions, the launch of AI products, and the full repayment of its $10 million line of credit from internally generated cash flow. The resignation of A. Hadi Chaudhry from the Board of Directors was for Nasdaq compliance and not due to any disagreement, with Mr. Chaudhry remaining as Chief Strategy Officer, making this a minor governance update.

At the time of this filing, CCLD was trading at $2.81 on NASDAQ in the Technology sector, with a market capitalization of approximately $112.8M. The 52-week trading range was $1.14 to $4.01. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CCLD - Latest Insights

CCLD
Jul 24, 2026, 5:00 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $2.22
Real-time Price: $2.22 info
Change: +$0.0024 (+0.11%) info
Market Cap: $100.283M info
CCLD
Jun 26, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.15
Real-time Price: $2.22 info
Change: +$0.0724 (+3%) info
Market Cap: $100.283M info
CCLD
Jun 26, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.15
Real-time Price: $2.22 info
Change: +$0.0724 (+3%) info
Market Cap: $100.283M info
CCLD
Jun 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.39
Real-time Price: $2.22 info
Change: -$0.1676 (-7%) info
Market Cap: $100.283M info
CCLD
Jun 05, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.35
Real-time Price: $2.22 info
Change: -$0.1276 (-5%) info
Market Cap: $100.283M info